Epigenetic Programming In Bronchopulmonary Dysplasia: A Framework Linking Early-Life Exposures To Persistent Lung Disease-A Narrative Review
For premature babies, a serious lung condition called bronchopulmonary dysplasia (BPD) has long been understood as a consequence of early lung injury. However, new insights suggest a more complex picture: BPD is now viewed as a disorder where early-life experiences fundamentally alter how a baby’s lungs develop and function long-term.
Imagine your genes as a set of instructions. While the basic instructions (your DNA) don’t change, “epigenetic mechanisms” are like switches that turn genes on or off, or dial their activity up or down. This review highlights how factors common in the lives of premature infants—such as high oxygen exposure (hyperoxia), inflammation, infections, and even certain medications—can create these epigenetic “switches.” These changes don’t alter the genetic code itself but profoundly influence how genes are expressed, impacting lung development.
The lasting impact of these early-life exposures means that individuals born prematurely may face reduced lung capacity, faster lung aging, and a higher risk of respiratory illnesses throughout their lives. This concept is framed as BPD being a disorder of “biological memory,” where the body essentially “remembers” these early environmental signals through epigenetic marks.
This new perspective is crucial because it shifts our focus towards identifying early indicators, known as epigenetic biomarkers, and developing new treatments that can specifically target these epigenetic changes. The goal is to improve not just the immediate health of premature infants, but their long-term well-being and quality of life.
Source: link to paper